IBUPROFEN 200MG

IBUPROFEN 200MG was reported 201324 times

IBUPROFEN 200MG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NSAID EXACERBATED RESPIRATORY DISEASE 186 0.4921
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 289 0.4326
2 DEEP VEIN THROMBOSIS POSTOPERATIVE 807 0.4029
3 DUODENAL ULCER PERFORATION 2919 0.3921
4 C-REACTIVE PROTEIN 355 0.3830
5 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2660 0.3709
6 MUSCLE INJURY 2958 0.3566
7 LUPUS VULGARIS 441 0.3500
8 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2228 0.3427
9 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 191 0.3405
10 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 699 0.3370
11 SWOLLEN JOINT COUNT INCREASED 1023 0.3205
12 ASPIRIN-EXACERBATED RESPIRATORY DISEASE 195 0.3171
13 X-RAY ABNORMAL 514 0.2872
14 RHEUMATIC FEVER 1274 0.2855
15 HELICOBACTER INFECTION 2852 0.2772
16 DISLOCATION OF VERTEBRA 632 0.2768
17 FOLLICULITIS 2882 0.2746
18 CROSS SENSITIVITY REACTION 247 0.2536
19 RHEUMATOID FACTOR POSITIVE 1451 0.2510
20 FACET JOINT SYNDROME 761 0.2335
21 PEMPHIGUS 2916 0.2330
22 HAND DEFORMITY 2828 0.2154
23 RETINITIS 345 0.1995
24 C-REACTIVE PROTEIN ABNORMAL 1245 0.1939
25 PERICARDITIS 3143 0.1869
26 ENTHESOPATHY 288 0.1840
27 PERIPHERAL VENOUS DISEASE 714 0.1747
28 SYNOVITIS 3133 0.1736
29 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 167 0.1573
30 GASTRIC ULCER PERFORATION 199 0.1569
31 PORPHYRIA ACUTE 220 0.1533
32 IRRITABLE BOWEL SYNDROME 3187 0.1485
33 SERONEGATIVE ARTHRITIS 164 0.1431
34 RENAL TUBULAR ACIDOSIS 291 0.1332
35 GLOSSODYNIA 2905 0.1296
36 FIXED ERUPTION 220 0.1278
37 DRUG TOLERANCE DECREASED 328 0.1167
38 DEATH NEONATAL 162 0.1164
39 NEPHROGENIC ANAEMIA 534 0.1152
40 LIP DRY 1044 0.1148
41 OBSTRUCTIVE SLEEP APNOEA SYNDROME 167 0.1145
42 TENOSYNOVITIS 308 0.1116
43 BLOOD PARATHYROID HORMONE DECREASED 165 0.1113
44 BILIARY DYSKINESIA 187 0.1101
45 CHOLECYSTITIS CHRONIC 727 0.1085
46 HYPERPARATHYROIDISM SECONDARY 265 0.1057
47 WOUND 2864 0.1024
48 IMPAIRED HEALING 3318 0.1010
49 LIP OEDEMA 424 0.1000
50 BONE EROSION 346 0.0977
51 RHEUMATOID NODULE 269 0.0976
52 GRIP STRENGTH DECREASED 857 0.0973
53 BREAST CANCER STAGE III 622 0.0959
54 BURSITIS 1157 0.0953
55 CONTRAINDICATED PRODUCT ADMINISTERED 2876 0.0949
56 AUTOIMMUNE DISORDER 914 0.0937
57 JOINT RANGE OF MOTION DECREASED 1235 0.0920
58 HYPERCHOLESTEROLAEMIA 873 0.0903
59 ANALGESIC DRUG LEVEL INCREASED 143 0.0890
60 MATERNAL EXPOSURE TIMING UNSPECIFIED 333 0.0886
61 LOWER RESPIRATORY TRACT INFECTION 4022 0.0883
62 MENINGITIS ASEPTIC 391 0.0870
63 SYSTEMIC LUPUS ERYTHEMATOSUS 3038 0.0855
64 REBOUND ACID HYPERSECRETION 257 0.0849
65 WOUND INFECTION 929 0.0847
66 FIBROMYALGIA 1987 0.0817
67 OLIGOHYDRAMNIOS 269 0.0806
68 PEPTIC ULCER 264 0.0795
69 DUODENAL ULCER 559 0.0792
70 DUODENAL ULCER HAEMORRHAGE 223 0.0779
71 TUBULOINTERSTITIAL NEPHRITIS 1452 0.0774
72 LIVER INJURY 1895 0.0771
73 EXOSTOSIS 677 0.0741
74 MUSCLE SPASTICITY 906 0.0737
75 PANNICULITIS 176 0.0727
76 KOUNIS SYNDROME 165 0.0726
77 SUSPECTED SUICIDE 340 0.0725
78 SELF-MEDICATION 297 0.0722
79 LIVE BIRTH 588 0.0702
80 BLISTER 3929 0.0699
81 GASTRITIS EROSIVE 326 0.0699
82 EXPOSURE TO TOXIC AGENT 223 0.0696
83 ALANINE AMINOTRANSFERASE ABNORMAL 146 0.0692
84 ARTHROPATHY 3842 0.0691
85 OBESITY 1098 0.0688
86 PSORIATIC ARTHROPATHY 2706 0.0666
87 THERAPEUTIC PRODUCT EFFECT DECREASED 2941 0.0656
88 PUSTULAR PSORIASIS 225 0.0654
89 RED BLOOD CELL SEDIMENTATION RATE INCREASED 721 0.0651
90 SCIATICA 1018 0.0638
91 ANGIOEDEMA 2811 0.0635
92 EAR PAIN 1234 0.0634
93 END STAGE RENAL DISEASE 1155 0.0633
94 PLANTAR FASCIITIS 212 0.0632
95 TOXIC EPIDERMAL NECROLYSIS 956 0.0629
96 NIGHT SWEATS 2025 0.0628
97 RENAL TUBULAR NECROSIS 613 0.0624
98 DISCOMFORT 3799 0.0622
99 STOMATITIS 3655 0.0602
100 SPONDYLITIS 217 0.0596
101 WALKING AID USER 389 0.0589
102 CHRONIC KIDNEY DISEASE 4459 0.0586
103 MULTIPLE DRUG OVERDOSE INTENTIONAL 188 0.0584
104 INTENTIONAL OVERDOSE 3748 0.0584
105 TYPE 2 DIABETES MELLITUS 1961 0.0582
106 ULCER HAEMORRHAGE 393 0.0580
107 GASTRIC ULCER 1097 0.0577
108 UPPER GASTROINTESTINAL HAEMORRHAGE 959 0.0569
109 FOOT DEFORMITY 604 0.0544
110 LOWER LIMB FRACTURE 1038 0.0540
111 HEPATIC ENZYME INCREASED 3680 0.0539
112 BLEPHAROSPASM 339 0.0538
113 GASTRIC ULCER HAEMORRHAGE 295 0.0532
114 INFUSION RELATED REACTION 3514 0.0530
115 JOINT SWELLING 6357 0.0526
116 ANKYLOSING SPONDYLITIS 692 0.0525
117 THROMBOPHLEBITIS SUPERFICIAL 156 0.0514
118 PRE-EXISTING CONDITION IMPROVED 320 0.0512
119 PRESCRIBED OVERDOSE 971 0.0501
120 SWELLING 4689 0.0501
121 INJURY 3516 0.0500
122 OSTEOARTHRITIS 2102 0.0495
123 MELAENA 1086 0.0493
124 RASH VESICULAR 238 0.0492
125 DUODENITIS 151 0.0492
126 HAEMATEMESIS 1246 0.0491
127 SINUSITIS 5019 0.0489
128 BODY TEMPERATURE INCREASED 993 0.0486
129 POISONING DELIBERATE 458 0.0483
130 SUICIDE ATTEMPT 2921 0.0481
131 PULMONARY FIBROSIS 923 0.0481
132 BRAIN NATRIURETIC PEPTIDE INCREASED 148 0.0480
133 EYE INJURY 144 0.0474
134 TONGUE OEDEMA 180 0.0471
135 HIP ARTHROPLASTY 722 0.0471
136 METABOLIC ACIDOSIS 1466 0.0458
137 MUSCULOSKELETAL STIFFNESS 3994 0.0455
138 NAIL DISORDER 397 0.0453
139 BLOOD CHOLESTEROL INCREASED 2090 0.0448
140 BREAST CANCER STAGE II 373 0.0448
141 ACUTE KIDNEY INJURY 6770 0.0442
142 FUNCTIONAL GASTROINTESTINAL DISORDER 152 0.0439
143 NECROTISING FASCIITIS 153 0.0434
144 GASTROINTESTINAL DISORDER 3886 0.0433
145 ILL-DEFINED DISORDER 2627 0.0432
146 ABDOMINAL TENDERNESS 213 0.0428
147 ACUTE HEPATIC FAILURE 585 0.0428
148 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 258 0.0424
149 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 329 0.0423
150 PERIORBITAL OEDEMA 217 0.0418
151 STEVENS-JOHNSON SYNDROME 923 0.0415
152 PATENT DUCTUS ARTERIOSUS 164 0.0413
153 MUSCULOSKELETAL PAIN 2162 0.0412
154 C-REACTIVE PROTEIN INCREASED 1481 0.0407
155 RHEUMATOID ARTHRITIS 4579 0.0403
156 JOINT DISLOCATION 425 0.0402
157 DRUG INTOLERANCE 3871 0.0400
158 HYPERACUSIS 149 0.0400
159 SKIN NECROSIS 207 0.0399
160 RESPIRATORY DISORDER 1178 0.0393
161 LUPUS-LIKE SYNDROME 357 0.0393
162 MULTIPLE DRUG OVERDOSE 195 0.0393
163 CHOLECYSTITIS ACUTE 222 0.0391
164 HEPATITIS ACUTE 253 0.0389
165 DRUG TOLERANCE 196 0.0387
166 JOINT EFFUSION 267 0.0387
167 INTERVERTEBRAL DISC DISORDER 165 0.0386
168 SPINAL OSTEOARTHRITIS 339 0.0385
169 GASTRITIS 1014 0.0385
170 FLANK PAIN 358 0.0382
171 SLEEP DISORDER 2690 0.0381
172 HEPATIC NECROSIS 143 0.0379
173 GAIT INABILITY 1260 0.0377
174 TONGUE DISORDER 272 0.0376
175 WHEEZING 2211 0.0372
176 PERIPHERAL SWELLING 5741 0.0372
177 GALLBLADDER DISORDER 662 0.0370
178 TENDERNESS 384 0.0368
179 CONTUSION 3547 0.0368
180 TENDONITIS 570 0.0368
181 OEDEMA 1985 0.0366
182 ULCER 579 0.0364
183 MOBILITY DECREASED 2603 0.0362
184 GASTRIC HAEMORRHAGE 416 0.0361
185 INFLAMMATION 1861 0.0360
186 RENAL INJURY 1067 0.0359
187 GENERAL PHYSICAL HEALTH DETERIORATION 4152 0.0359
188 COMPLETED SUICIDE 2971 0.0356
189 MYOSITIS 319 0.0355
190 EYELID OEDEMA 411 0.0353
191 FACE OEDEMA 596 0.0353
192 DRUG-INDUCED LIVER INJURY 1094 0.0348
193 ANHEDONIA 911 0.0346
194 ANAPHYLACTIC REACTION 1897 0.0343
195 KNEE ARTHROPLASTY 722 0.0343
196 ABDOMINAL DISCOMFORT 5678 0.0338
197 HYPOTHERMIA 331 0.0327
198 GASTROINTESTINAL TOXICITY 157 0.0326
199 JOINT STIFFNESS 857 0.0326
200 UTERINE PERFORATION 276 0.0326
201 EAR INFECTION 867 0.0325
202 ROAD TRAFFIC ACCIDENT 1362 0.0325
203 ECONOMIC PROBLEM 492 0.0324
204 THERAPY NON-RESPONDER 1457 0.0324
205 ACIDOSIS 247 0.0323
206 INTERVERTEBRAL DISC DEGENERATION 299 0.0323
207 URTICARIA 5402 0.0322
208 INFECTION 4656 0.0321
209 OESOPHAGITIS 349 0.0319
210 HYPERSENSITIVITY 5926 0.0319
211 SPINAL PAIN 374 0.0319
212 SYNOVIAL CYST 146 0.0316
213 TENDON DISORDER 206 0.0316
214 NASOPHARYNGITIS 5819 0.0315
215 ERYTHEMA MULTIFORME 294 0.0315
216 MATERNAL EXPOSURE DURING PREGNANCY 2803 0.0314
217 SLEEP APNOEA SYNDROME 593 0.0310
218 HEPATITIS CHOLESTATIC 187 0.0310
219 CONFUSIONAL STATE 5016 0.0310
220 PREGNANCY 620 0.0309
221 DELIRIUM 1072 0.0309
222 CHOLECYSTITIS 367 0.0308
223 IRON DEFICIENCY ANAEMIA 284 0.0307
224 UMBILICAL HERNIA 142 0.0304
225 SENSATION OF FOREIGN BODY 256 0.0303
226 RENAL CYST 241 0.0303
227 FOOT OPERATION 150 0.0303
228 CHOLELITHIASIS 985 0.0300
229 MUSCLE STRAIN 259 0.0299
230 ENDOMETRIOSIS 142 0.0298
231 LIGAMENT SPRAIN 294 0.0297
232 PHARYNGITIS 366 0.0295
233 PSYCHOLOGICAL TRAUMA 253 0.0293
234 HYPERTRANSAMINASAEMIA 203 0.0292
235 INTERVERTEBRAL DISC PROTRUSION 638 0.0292
236 LUNG DISORDER 1424 0.0290
237 MIGRAINE 2764 0.0289
238 PRODUCT ADMINISTRATION INTERRUPTED 227 0.0289
239 ABDOMINAL PAIN UPPER 5942 0.0288
240 POST-TRAUMATIC STRESS DISORDER 193 0.0288
241 ATRIAL SEPTAL DEFECT 240 0.0286
242 VENTRICULAR SEPTAL DEFECT 164 0.0286
243 TOXICITY TO VARIOUS AGENTS 4828 0.0286
244 DRUG ERUPTION 507 0.0286
245 RENAL FAILURE ACUTE 1214 0.0286
246 JOINT INJURY 604 0.0282
247 VITAMIN D DEFICIENCY 274 0.0281
248 BACK DISORDER 456 0.0280
249 TOOTH INFECTION 369 0.0280
250 HYPERCALCAEMIA 345 0.0279
251 LIP SWELLING 930 0.0279
252 NECK PAIN 1555 0.0278
253 LYMPHOEDEMA 192 0.0277
254 DEEP VEIN THROMBOSIS 1801 0.0277
255 HIATUS HERNIA 357 0.0275
256 LIVER DISORDER 1221 0.0275
257 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 141 0.0275
258 POISONING 345 0.0274
259 HEPATIC STEATOSIS 509 0.0273
260 ATELECTASIS 264 0.0273
261 HYPERVENTILATION 157 0.0271
262 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 464 0.0270
263 OSTEOPENIA 410 0.0270
264 RENAL FAILURE 3583 0.0270
265 PLEURISY 160 0.0269
266 POLYURIA 220 0.0268
267 GASTROOESOPHAGEAL REFLUX DISEASE 2160 0.0268
268 INTENTIONAL SELF-INJURY 540 0.0267
269 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 236 0.0267
270 LEUKOCYTOSIS 483 0.0267
271 ARTHRALGIA 11064 0.0266
272 ANURIA 229 0.0266
273 TRICUSPID VALVE INCOMPETENCE 211 0.0265
274 PRESCRIBED UNDERDOSE 529 0.0265
275 HEPATIC CIRRHOSIS 493 0.0262
276 CONGENITAL ANOMALY 202 0.0261
277 NEPHROPATHY 243 0.0260
278 DRY MOUTH 2111 0.0260
279 TOOTH FRACTURE 286 0.0259
280 STREPTOCOCCAL INFECTION 144 0.0259
281 TASTE DISORDER 524 0.0258
282 GASTROINTESTINAL HAEMORRHAGE 2156 0.0258
283 RASH MACULO-PAPULAR 573 0.0257
284 NEURALGIA 624 0.0256
285 HYPOAESTHESIA 3840 0.0256
286 OLIGURIA 159 0.0256
287 ABNORMAL LOSS OF WEIGHT 174 0.0255
288 LARYNGEAL OEDEMA 157 0.0254
289 DISABILITY 503 0.0254
290 DERMATITIS BULLOUS 184 0.0254
291 NEPHROLITHIASIS 1161 0.0253
292 SEASONAL ALLERGY 357 0.0252
293 SINUS TACHYCARDIA 358 0.0252
294 ALOPECIA 4941 0.0251
295 TREATMENT FAILURE 2079 0.0251
296 HYPERAESTHESIA 206 0.0251
297 FAECES DISCOLOURED 543 0.0250
298 COAGULOPATHY 417 0.0250
299 BASAL CELL CARCINOMA 390 0.0250
300 ROTATOR CUFF SYNDROME 320 0.0249
301 MENISCUS INJURY 153 0.0249
302 NEPHROPATHY TOXIC 279 0.0248
303 GENERAL SYMPTOM 186 0.0248
304 VITAMIN D DECREASED 212 0.0248
305 PAIN 15218 0.0247
306 DYSPEPSIA 2418 0.0246
307 SINUS HEADACHE 146 0.0246
308 OSTEOPOROSIS 1005 0.0244
309 NERVE INJURY 271 0.0243
310 CORONAVIRUS INFECTION 161 0.0243
311 ARTHRITIS 1913 0.0243
312 INFUSION SITE SWELLING 153 0.0243
313 PROTHROMBIN TIME PROLONGED 145 0.0242
314 MUSCULOSKELETAL CHEST PAIN 374 0.0241
315 DRUG TOXICITY 329 0.0241
316 OBSTRUCTIVE AIRWAYS DISORDER 268 0.0241
317 LOWER GASTROINTESTINAL HAEMORRHAGE 178 0.0241
318 MUSCULOSKELETAL DISCOMFORT 414 0.0240
319 HAEMODYNAMIC INSTABILITY 183 0.0240
320 INTENTIONAL PRODUCT USE ISSUE 2104 0.0240
321 MEDICATION ERROR 1333 0.0240
322 AGRANULOCYTOSIS 445 0.0239
323 OVARIAN CYST 239 0.0239
324 WEIGHT INCREASED 5351 0.0239
325 HYPERLIPIDAEMIA 285 0.0238
326 MAJOR DEPRESSION 174 0.0238
327 GROIN PAIN 209 0.0238
328 DIVERTICULUM 169 0.0238
329 UPPER RESPIRATORY TRACT INFECTION 1097 0.0237
330 SHOCK 546 0.0237
331 ELECTROCARDIOGRAM ABNORMAL 186 0.0237
332 ALANINE AMINOTRANSFERASE INCREASED 1454 0.0237
333 UTERINE LEIOMYOMA 173 0.0236
334 AMNESIA 1537 0.0236
335 PHARYNGEAL SWELLING 231 0.0236
336 JAUNDICE 635 0.0236
337 INGUINAL HERNIA 143 0.0235
338 GASTROINTESTINAL PAIN 258 0.0234
339 HYPOKALAEMIA 1082 0.0234
340 TENDON PAIN 177 0.0234
341 BACK INJURY 254 0.0233
342 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 599 0.0233
343 SEDATION 609 0.0232
344 WEIGHT FLUCTUATION 243 0.0232
345 CARPAL TUNNEL SYNDROME 324 0.0231
346 PYREXIA 7976 0.0230
347 DRUG SCREEN POSITIVE 182 0.0230
348 BACK PAIN 5347 0.0230
349 AUTOIMMUNE HEPATITIS 160 0.0230
350 IMPAIRED GASTRIC EMPTYING 313 0.0229
351 EOSINOPHILIA 402 0.0229
352 PELVIC PAIN 416 0.0229
353 CHOLECYSTECTOMY 261 0.0228
354 CIRCULATORY COLLAPSE 387 0.0227
355 HEPATOMEGALY 222 0.0226
356 NIGHTMARE 781 0.0225
357 TOOTHACHE 408 0.0225
358 COLITIS ISCHAEMIC 152 0.0225
359 ABDOMINAL PAIN 5222 0.0224
360 SINUS CONGESTION 303 0.0224
361 LIVER FUNCTION TEST INCREASED 481 0.0224
362 TOOTH ABSCESS 228 0.0224
363 MULTIPLE ALLERGIES 175 0.0223
364 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1071 0.0223
365 BODY TEMPERATURE DECREASED 219 0.0222
366 TRANSAMINASES INCREASED 494 0.0222
367 QUALITY OF LIFE DECREASED 298 0.0222
368 PARAESTHESIA 3490 0.0222
369 LACTIC ACIDOSIS 718 0.0221
370 CHEST PAIN 4105 0.0221
371 TACHYCARDIA 1968 0.0221
372 ANKLE FRACTURE 341 0.0220
373 HEAD DISCOMFORT 389 0.0220
374 SOMNAMBULISM 144 0.0219
375 SPLENOMEGALY 257 0.0219
376 DEPRESSION 4981 0.0219
377 SUBSTANCE ABUSE 178 0.0218
378 SHOCK HAEMORRHAGIC 178 0.0218
379 TACHYPNOEA 297 0.0218
380 ENCEPHALITIS 151 0.0218
381 BRONCHOSPASM 311 0.0218
382 NERVE COMPRESSION 201 0.0218
383 CONJUNCTIVITIS 404 0.0218
384 PULMONARY CONGESTION 287 0.0217
385 ANXIETY 6181 0.0217
386 ABDOMINAL PAIN LOWER 548 0.0216
387 PHOTOPHOBIA 406 0.0216
388 PULMONARY EMBOLISM 2049 0.0215
389 MUSCLE TIGHTNESS 349 0.0215
390 VOMITING 10128 0.0215
391 HAEMATOCHEZIA 1188 0.0215
392 PRODUCT PRESCRIBING ERROR 512 0.0215
393 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 146 0.0215
394 RHINITIS 173 0.0214
395 PULMONARY TOXICITY 151 0.0213
396 COMA 1016 0.0213
397 LARGE INTESTINE POLYP 147 0.0212
398 ASPARTATE AMINOTRANSFERASE INCREASED 1126 0.0212
399 EXPOSURE DURING PREGNANCY 1313 0.0211
400 LYMPHOCYTE COUNT DECREASED 372 0.0210
401 HEPATOTOXICITY 468 0.0210
402 RASH 9150 0.0210
403 ACUTE RESPIRATORY DISTRESS SYNDROME 371 0.0210
404 CHROMATURIA 472 0.0209
405 PRURITUS 8029 0.0209
406 OBSESSIVE-COMPULSIVE DISORDER 167 0.0208
407 HYSTERECTOMY 180 0.0208
408 RASH PRURITIC 1126 0.0208
409 HAEMORRHOIDS 405 0.0207
410 FEELING DRUNK 154 0.0207
411 INSOMNIA 5512 0.0207
412 MUSCULAR WEAKNESS 2351 0.0207
413 SECRETION DISCHARGE 259 0.0207
414 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 351 0.0206
415 OEDEMA PERIPHERAL 2512 0.0206
416 NEPHROTIC SYNDROME 141 0.0205
417 DENTAL CARIES 227 0.0205
418 ASTHMA 2316 0.0205
419 MUSCLE TWITCHING 472 0.0205
420 HYPERTENSION 4323 0.0204
421 CONDITION AGGRAVATED 6202 0.0204
422 RECTAL HAEMORRHAGE 875 0.0203
423 PAIN IN EXTREMITY 5996 0.0203
424 BRAIN INJURY 204 0.0203
425 DYSSTASIA 594 0.0203
426 PANCREATITIS ACUTE 455 0.0202
427 SWOLLEN TONGUE 632 0.0202
428 ATAXIA 240 0.0202
429 GAIT DISTURBANCE 3863 0.0202
430 SKIN INFECTION 226 0.0201
431 DEPRESSED LEVEL OF CONSCIOUSNESS 794 0.0201
432 SCAR 343 0.0200
433 URINE OUTPUT DECREASED 175 0.0200
434 EPILEPSY 608 0.0199
435 COORDINATION ABNORMAL 276 0.0198
436 BLOOD UREA INCREASED 331 0.0197
437 TINNITUS 908 0.0197
438 RESTLESS LEGS SYNDROME 359 0.0197
439 LYMPHADENOPATHY 698 0.0197
440 RESPIRATORY DEPRESSION 241 0.0196
441 HYPERKALAEMIA 689 0.0196
442 UNRESPONSIVE TO STIMULI 506 0.0196
443 DRUG INTERACTION 3107 0.0196
444 CYST 243 0.0196
445 HEADACHE 12251 0.0195
446 FOOT FRACTURE 370 0.0195
447 SWELLING FACE 1263 0.0194
448 SENSORY LOSS 156 0.0194
449 CARDIOMEGALY 238 0.0193
450 MULTIPLE ORGAN DYSFUNCTION SYNDROME 548 0.0193
451 SKIN ULCER 499 0.0193
452 IMPAIRED QUALITY OF LIFE 275 0.0191
453 MUSCULOSKELETAL DISORDER 364 0.0191
454 PNEUMOTHORAX 303 0.0191
455 FEELING HOT 1168 0.0190
456 DECREASED APPETITE 4421 0.0190
457 SPINAL DISORDER 180 0.0190
458 THROAT TIGHTNESS 514 0.0190
459 FEELING COLD 529 0.0190
460 MICTURITION URGENCY 217 0.0190
461 PARAESTHESIA ORAL 274 0.0190
462 KIDNEY INFECTION 372 0.0189
463 CARDIAC MURMUR 164 0.0189
464 BLOOD CALCIUM DECREASED 213 0.0189
465 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1347 0.0189
466 INFUSION SITE PAIN 244 0.0189
467 FOOD ALLERGY 146 0.0189
468 MITRAL VALVE INCOMPETENCE 214 0.0189
469 APNOEA 147 0.0189
470 FATIGUE 14701 0.0189
471 HAEMATOMA 489 0.0189
472 LIMB DISCOMFORT 584 0.0189
473 DYSPNOEA 10667 0.0188
474 BRAIN OEDEMA 238 0.0188
475 RESPIRATORY TRACT CONGESTION 299 0.0188
476 EAR DISCOMFORT 193 0.0188
477 DYSPNOEA EXERTIONAL 707 0.0188
478 SKIN LACERATION 204 0.0187
479 TENDON RUPTURE 231 0.0187
480 HEPATIC FAILURE 564 0.0187
481 FACIAL PAIN 167 0.0187
482 HYPERHIDROSIS 2408 0.0187
483 MUSCLE SPASMS 3419 0.0186
484 INITIAL INSOMNIA 191 0.0186
485 SOMNOLENCE 3726 0.0185
486 CELLULITIS 931 0.0185
487 PYELONEPHRITIS 160 0.0184
488 DYSURIA 679 0.0184
489 FEAR 496 0.0184
490 HEPATIC CYTOLYSIS 235 0.0184
491 PHARYNGITIS STREPTOCOCCAL 199 0.0184
492 BLOOD IRON DECREASED 218 0.0184
493 LUNG INFILTRATION 162 0.0183
494 NOCTURIA 222 0.0183
495 INFUSION SITE ERYTHEMA 154 0.0182
496 BLOOD PRESSURE SYSTOLIC INCREASED 356 0.0182
497 MYOCARDITIS 209 0.0182
498 GASTROENTERITIS 266 0.0182
499 BIPOLAR DISORDER 198 0.0182
500 INFLUENZA LIKE ILLNESS 1499 0.0182
501 WHITE BLOOD CELL COUNT INCREASED 697 0.0181
502 NEUTROPHIL COUNT INCREASED 186 0.0181
503 RIB FRACTURE 373 0.0181
504 SMALL INTESTINAL OBSTRUCTION 223 0.0181
505 HYPOKINESIA 263 0.0181
506 LETHARGY 1038 0.0180
507 COLD SWEAT 317 0.0180
508 SKIN LESION 493 0.0180
509 MUSCLE ATROPHY 227 0.0179
510 HYPOAESTHESIA ORAL 270 0.0179
511 ASPIRATION 196 0.0179
512 URINARY INCONTINENCE 529 0.0178
513 MEMORY IMPAIRMENT 2448 0.0178
514 HAEMATOCRIT DECREASED 353 0.0178
515 MOUTH ULCERATION 375 0.0178
516 OROPHARYNGEAL PAIN 1647 0.0178
517 ANAL INCONTINENCE 160 0.0178
518 PRURITUS GENERALISED 384 0.0177
519 BLADDER DISORDER 176 0.0177
520 RESTLESSNESS 648 0.0177
521 DISTURBANCE IN ATTENTION 953 0.0177
522 MYDRIASIS 226 0.0176
523 BONE DISORDER 321 0.0176
524 GAMMA-GLUTAMYLTRANSFERASE INCREASED 390 0.0176
525 EMOTIONAL DISTRESS 2130 0.0176
526 PERSONALITY CHANGE 163 0.0175
527 TEMPERATURE INTOLERANCE 181 0.0175
528 CHEST DISCOMFORT 1796 0.0175
529 SENSORY DISTURBANCE 281 0.0175
530 UVEITIS 237 0.0175
531 MENTAL STATUS CHANGES 484 0.0174
532 DECREASED ACTIVITY 188 0.0174
533 PANIC ATTACK 634 0.0174
534 RESPIRATORY TRACT INFECTION 453 0.0174
535 POOR QUALITY SLEEP 374 0.0174
536 NAUSEA 13732 0.0173
537 PETECHIAE 181 0.0173
538 BLOOD ALKALINE PHOSPHATASE INCREASED 430 0.0173
539 NASAL CONGESTION 1017 0.0173
540 ELECTROLYTE IMBALANCE 201 0.0173
541 ASTHENIA 6498 0.0173
542 DRUG ABUSE 1438 0.0173
543 DERMATITIS CONTACT 197 0.0173
544 CORONARY ARTERY DISEASE 523 0.0173
545 AGITATION 1258 0.0171
546 IMPAIRED WORK ABILITY 366 0.0171
547 CHILLS 2001 0.0171
548 HEPATITIS 436 0.0170
549 INFLAMMATORY BOWEL DISEASE 166 0.0169
550 MENORRHAGIA 333 0.0169
551 PALLOR 461 0.0169
552 GLOMERULAR FILTRATION RATE DECREASED 208 0.0169
553 DYSARTHRIA 637 0.0169
554 SUPRAVENTRICULAR TACHYCARDIA 162 0.0169
555 EYE SWELLING 629 0.0169
556 ORAL HERPES 330 0.0169
557 INTENTIONAL PRODUCT MISUSE 1478 0.0169
558 POLYNEUROPATHY 202 0.0169
559 HEPATOCELLULAR INJURY 239 0.0168
560 PHOTOSENSITIVITY REACTION 277 0.0168
561 BRONCHITIS 1239 0.0167
562 PROTEINURIA 318 0.0167
563 EATING DISORDER 356 0.0167
564 BLOOD CREATININE INCREASED 1089 0.0167
565 INCONTINENCE 176 0.0166
566 DIZZINESS 8300 0.0166
567 ANAPHYLACTIC SHOCK 429 0.0166
568 INADEQUATE ANALGESIA 141 0.0166
569 HEMIPARESIS 281 0.0166
570 THROAT IRRITATION 744 0.0166
571 RESPIRATORY ARREST 457 0.0166
572 TOOTH DISORDER 368 0.0165
573 SYNCOPE 1654 0.0165
574 PURPURA 146 0.0165
575 DIVERTICULITIS 457 0.0165
576 RESPIRATORY DISTRESS 455 0.0165
577 OPTIC NEURITIS 149 0.0164
578 CHOLESTASIS 314 0.0163
579 LIVER FUNCTION TEST ABNORMAL 475 0.0163
580 SUICIDAL IDEATION 1494 0.0163
581 PHARYNGEAL OEDEMA 251 0.0163
582 APHASIA 492 0.0163
583 CARDIO-RESPIRATORY ARREST 678 0.0162
584 PRODUCT USE ISSUE 3044 0.0162
585 DEPRESSED MOOD 854 0.0161
586 HOT FLUSH 1216 0.0161
587 SPUTUM DISCOLOURED 153 0.0161
588 THIRST 288 0.0161
589 PERIPHERAL COLDNESS 221 0.0161
590 GASTRIC DISORDER 552 0.0161
591 DISORIENTATION 637 0.0161
592 MENTAL DISORDER 699 0.0160
593 PULMONARY MASS 239 0.0160
594 BREAST PAIN 171 0.0160
595 PARANOIA 276 0.0160
596 ACCIDENTAL OVERDOSE 585 0.0160
597 DYSMENORRHOEA 212 0.0160
598 POST PROCEDURAL HAEMORRHAGE 186 0.0160
599 HYPERBILIRUBINAEMIA 165 0.0159
600 HYPOTONIA 159 0.0159
601 VIRAL INFECTION 530 0.0159
602 SEROTONIN SYNDROME 305 0.0159
603 RENAL PAIN 168 0.0158
604 ARTERIOSCLEROSIS 149 0.0158
605 HUNGER 220 0.0158
606 BALANCE DISORDER 1364 0.0158
607 APATHY 230 0.0158
608 INCREASED TENDENCY TO BRUISE 145 0.0157
609 OVERDOSE 3397 0.0157
610 BONE PAIN 922 0.0157
611 PALPITATIONS 1842 0.0157
612 ORAL DISCOMFORT 217 0.0156
613 DYSPHONIA 912 0.0156
614 VERTIGO 945 0.0155
615 DERMATITIS ALLERGIC 195 0.0155
616 MOVEMENT DISORDER 497 0.0155
617 GENERALISED TONIC-CLONIC SEIZURE 256 0.0155
618 MYALGIA 2628 0.0154
619 INSURANCE ISSUE 236 0.0154
620 WEIGHT DECREASED 4303 0.0154
621 HYPOTENSION 3091 0.0154
622 VENTRICULAR EXTRASYSTOLES 160 0.0154
623 BLOOD BILIRUBIN INCREASED 416 0.0154
624 PANCREATITIS 813 0.0154
625 PAIN IN JAW 435 0.0153
626 GOUT 275 0.0153
627 MOTOR DYSFUNCTION 156 0.0153
628 HYPONATRAEMIA 860 0.0153
629 DIARRHOEA 9842 0.0152
630 HEPATIC ENCEPHALOPATHY 142 0.0152
631 HAIR COLOUR CHANGES 188 0.0151
632 HAEMATURIA 516 0.0151
633 LIMB INJURY 409 0.0150
634 PRESYNCOPE 366 0.0150
635 ORAL PAIN 337 0.0150
636 DYSPHAGIA 1424 0.0150
637 BLOOD POTASSIUM DECREASED 451 0.0150
638 ADVERSE DRUG REACTION 1347 0.0150
639 PRODUCT ADMINISTRATION ERROR 303 0.0150
640 CANDIDA INFECTION 253 0.0150
641 RETCHING 319 0.0149
642 MOOD SWINGS 476 0.0149
643 FOETAL EXPOSURE DURING PREGNANCY 1213 0.0149
644 RHINORRHOEA 964 0.0149
645 OSTEOMYELITIS 270 0.0149
646 SINUS BRADYCARDIA 144 0.0149
647 SINUS DISORDER 295 0.0149
648 PRODUCT USE IN UNAPPROVED INDICATION 3690 0.0149
649 CRYING 541 0.0149
650 ACUTE RESPIRATORY FAILURE 286 0.0149
651 DRUG LEVEL INCREASED 246 0.0148
652 GINGIVAL BLEEDING 202 0.0148
653 CONSTIPATION 3226 0.0148
654 ANAEMIA 2817 0.0148
655 PSORIASIS 1929 0.0148
656 THERAPEUTIC RESPONSE UNEXPECTED 662 0.0147
657 BLOOD SODIUM DECREASED 278 0.0147
658 HEART RATE IRREGULAR 333 0.0147
659 COUGH 4127 0.0147
660 HYPOXIA 517 0.0147
661 PSYCHOMOTOR HYPERACTIVITY 243 0.0146
662 RASH PAPULAR 328 0.0146
663 HYPOPHAGIA 374 0.0146
664 EYE INFECTION 165 0.0146
665 URINARY TRACT INFECTION 2485 0.0146
666 MULTIPLE SCLEROSIS RELAPSE 998 0.0145
667 HYPERSOMNIA 417 0.0145
668 FLUSHING 1477 0.0145
669 VASCULITIS 169 0.0145
670 RASH MACULAR 507 0.0145
671 MADAROSIS 168 0.0145
672 LOCALISED INFECTION 350 0.0145
673 EYE PAIN 811 0.0144
674 WRIST FRACTURE 172 0.0143
675 RHABDOMYOLYSIS 598 0.0143
676 MYOCARDIAL ISCHAEMIA 163 0.0143
677 SCRATCH 151 0.0143
678 POLLAKIURIA 597 0.0143
679 BRADYCARDIA 759 0.0143
680 ORAL CANDIDIASIS 188 0.0143
681 EUPHORIC MOOD 146 0.0142
682 PROCEDURAL PAIN 395 0.0142
683 RENAL IMPAIRMENT 1195 0.0142
684 DIPLOPIA 369 0.0142
685 SCAB 162 0.0142
686 RASH ERYTHEMATOUS 679 0.0142
687 HYPERTENSIVE CRISIS 158 0.0142
688 BURNING SENSATION 995 0.0142
689 EMPHYSEMA 143 0.0142
690 BLOOD URINE PRESENT 269 0.0142
691 URINARY RETENTION 472 0.0141
692 HAEMOGLOBIN DECREASED 1452 0.0141
693 MIDDLE INSOMNIA 264 0.0141
694 CYSTITIS 449 0.0141
695 INFLUENZA 1572 0.0141
696 LOSS OF CONSCIOUSNESS 1805 0.0141
697 IMMUNODEFICIENCY 210 0.0141
698 DEHYDRATION 1874 0.0140
699 PRODUCTIVE COUGH 670 0.0140
700 ILEUS 174 0.0140
701 BONE DENSITY DECREASED 438 0.0140
702 CYANOSIS 219 0.0139
703 HALLUCINATION, VISUAL 294 0.0139
704 FEEDING DISORDER 282 0.0139
705 BLOOD PRESSURE FLUCTUATION 333 0.0139
706 ANGINA PECTORIS 396 0.0138
707 MULTIPLE SCLEROSIS 660 0.0138
708 HAEMOPTYSIS 385 0.0138
709 MALAISE 6044 0.0138
710 COLITIS 522 0.0138
711 FALL 4577 0.0137
712 COGNITIVE DISORDER 642 0.0137
713 SOPOR 182 0.0137
714 ADVERSE EVENT 1265 0.0137
715 IMPAIRED DRIVING ABILITY 156 0.0137
716 SICKLE CELL ANAEMIA WITH CRISIS 216 0.0137
717 LOCAL SWELLING 239 0.0137
718 THINKING ABNORMAL 255 0.0137
719 HAIR TEXTURE ABNORMAL 183 0.0137
720 GASTROENTERITIS VIRAL 247 0.0137
721 MASS 191 0.0137
722 INTESTINAL PERFORATION 153 0.0136
723 ENCEPHALOPATHY 334 0.0136
724 ABSCESS 217 0.0136
725 HEART RATE INCREASED 1346 0.0136
726 CARDIAC ARREST 1120 0.0136
727 ACUTE MYOCARDIAL INFARCTION 400 0.0136
728 VISION BLURRED 1860 0.0135
729 ERYTHEMA 2780 0.0135
730 MULTIPLE FRACTURES 222 0.0135
731 TOOTH LOSS 280 0.0135
732 HYPOTHYROIDISM 431 0.0135
733 FLUID RETENTION 686 0.0135
734 SKIN HAEMORRHAGE 199 0.0134
735 STAPHYLOCOCCAL INFECTION 442 0.0134
736 LEUKOPENIA 670 0.0134
737 THERAPEUTIC RESPONSE DECREASED 809 0.0133
738 HERNIA 257 0.0133
739 IMMUNE SYSTEM DISORDER 175 0.0133
740 DERMATITIS 278 0.0133
741 FEELING ABNORMAL 3179 0.0133
742 BLOOD LACTATE DEHYDROGENASE INCREASED 210 0.0132
743 LABORATORY TEST ABNORMAL 391 0.0132
744 SPINAL OPERATION 163 0.0132
745 EYE DISORDER 435 0.0132
746 PNEUMONIA 4278 0.0132
747 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 723 0.0132
748 MUCOSAL INFLAMMATION 344 0.0131
749 ACTIVITIES OF DAILY LIVING IMPAIRED 260 0.0131
750 IRRITABILITY 789 0.0131
751 SNEEZING 294 0.0131
752 BONE LOSS 197 0.0131
753 EPISTAXIS 978 0.0131
754 OXYGEN SATURATION DECREASED 734 0.0130
755 DYSGEUSIA 964 0.0130
756 PERICARDIAL EFFUSION 300 0.0130
757 MALNUTRITION 145 0.0129
758 HYPERGLYCAEMIA 472 0.0129
759 ABDOMINAL DISTENSION 1352 0.0129
760 SKIN DISORDER 432 0.0129
761 ADRENAL INSUFFICIENCY 157 0.0129
762 PLEURAL EFFUSION 787 0.0129
763 ACCIDENT 154 0.0129
764 ANGER 436 0.0129
765 TREMOR 2126 0.0128
766 SEIZURE 1478 0.0128
767 PULMONARY HYPERTENSION 266 0.0128
768 OCULAR DISCOMFORT 143 0.0127
769 INTERNATIONAL NORMALISED RATIO INCREASED 363 0.0127
770 VISUAL IMPAIRMENT 1572 0.0127
771 EXPIRED PRODUCT ADMINISTERED 420 0.0126
772 ELECTROCARDIOGRAM QT PROLONGED 454 0.0126
773 BLOOD TRIGLYCERIDES INCREASED 223 0.0126
774 FREQUENT BOWEL MOVEMENTS 340 0.0126
775 MYOCLONUS 150 0.0126
776 STATUS EPILEPTICUS 142 0.0126
777 BRAIN FOG 197 0.0126
778 BEDRIDDEN 165 0.0125
779 BACTERIAL INFECTION 234 0.0125
780 BLOOD PRESSURE INCREASED 1917 0.0125
781 COVID-19 2194 0.0125
782 SKIN DISCOLOURATION 574 0.0125
783 FUNGAL INFECTION 416 0.0125
784 ATRIAL FIBRILLATION 1212 0.0124
785 CENTRAL NERVOUS SYSTEM LESION 171 0.0124
786 PLATELET COUNT INCREASED 162 0.0124
787 HEART RATE DECREASED 436 0.0124
788 RESPIRATORY FAILURE 903 0.0124
789 SEPSIS 1381 0.0124
790 TOOTH EXTRACTION 154 0.0124
791 HALLUCINATION 928 0.0123
792 RASH GENERALISED 318 0.0123
793 SEPTIC SHOCK 530 0.0122
794 FEELING JITTERY 231 0.0121
795 SURGERY 710 0.0121
796 DRUG INEFFECTIVE 15937 0.0121
797 COVID-19 PNEUMONIA 142 0.0120
798 DRY EYE 600 0.0120
799 SPEECH DISORDER 629 0.0120
800 NEUROPATHY PERIPHERAL 1141 0.0120
801 LACRIMATION INCREASED 362 0.0120
802 RED BLOOD CELL COUNT DECREASED 342 0.0120
803 ALTERED STATE OF CONSCIOUSNESS 258 0.0119
804 WITHDRAWAL SYNDROME 500 0.0119
805 INTENTIONAL DOSE OMISSION 339 0.0119
806 ABORTION SPONTANEOUS 476 0.0119
807 RENAL DISORDER 551 0.0118
808 POST PROCEDURAL COMPLICATION 226 0.0118
809 AGGRESSION 587 0.0117
810 NODULE 153 0.0117
811 CARDIOMYOPATHY 173 0.0117
812 OSTEONECROSIS OF JAW 289 0.0117
813 BLOOD PRESSURE ABNORMAL 231 0.0116
814 ORTHOSTATIC HYPOTENSION 202 0.0116
815 MOOD ALTERED 316 0.0116
816 CARDIOGENIC SHOCK 166 0.0116
817 BLOOD PRESSURE DECREASED 767 0.0115
818 APHONIA 161 0.0115
819 ARRHYTHMIA 546 0.0115
820 HYPOCALCAEMIA 218 0.0115
821 FLATULENCE 653 0.0115
822 SKIN FISSURES 225 0.0115
823 PULMONARY OEDEMA 515 0.0115
824 ABNORMAL DREAMS 317 0.0115
825 HERPES ZOSTER 658 0.0114
826 COLITIS ULCERATIVE 510 0.0114
827 TREATMENT NONCOMPLIANCE 620 0.0113
828 HALLUCINATION, AUDITORY 180 0.0113
829 PNEUMONIA ASPIRATION 282 0.0113
830 THERAPEUTIC RESPONSE SHORTENED 374 0.0113
831 CARDIOVASCULAR DISORDER 286 0.0113
832 PRODUCT DOSE OMISSION IN ERROR 319 0.0113
833 PARALYSIS 161 0.0112
834 ADVERSE REACTION 149 0.0112
835 DISSEMINATED INTRAVASCULAR COAGULATION 158 0.0112
836 HYPERTHYROIDISM 162 0.0112
837 EJECTION FRACTION DECREASED 173 0.0111
838 PNEUMONITIS 301 0.0110
839 UPPER LIMB FRACTURE 220 0.0110
840 DRUG EFFECT LESS THAN EXPECTED 163 0.0110
841 MALIGNANT MELANOMA 147 0.0110
842 ABASIA 271 0.0110
843 SUBDURAL HAEMATOMA 157 0.0110
844 EMOTIONAL DISORDER 338 0.0110
845 ILLNESS 1128 0.0109
846 SPINAL FRACTURE 219 0.0109
847 DYSKINESIA 444 0.0109
848 MENTAL IMPAIRMENT 264 0.0109
849 LYMPHOPENIA 154 0.0109
850 TRANSIENT ISCHAEMIC ATTACK 367 0.0109
851 AGEUSIA 269 0.0108
852 BLOOD CREATINE PHOSPHOKINASE INCREASED 310 0.0108
853 HEAD INJURY 339 0.0107
854 DEAFNESS 280 0.0107
855 HYPOGLYCAEMIA 518 0.0107
856 FRACTURE 202 0.0107
857 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 552 0.0106
858 NERVOUSNESS 551 0.0105
859 PANCYTOPENIA 589 0.0105
860 SKIN REACTION 148 0.0105
861 DISEASE RECURRENCE 498 0.0105
862 THROMBOCYTOPENIA 1167 0.0104
863 ERUCTATION 201 0.0104
864 ECZEMA 542 0.0103
865 THERAPY PARTIAL RESPONDER 160 0.0102
866 DIABETES MELLITUS 779 0.0102
867 THROMBOSIS 819 0.0102
868 METASTASES TO BONE 166 0.0101
869 CATARACT 601 0.0101
870 INTENTIONAL DRUG MISUSE 211 0.0101
871 ERECTILE DYSFUNCTION 259 0.0101
872 OFF LABEL USE 8772 0.0100
873 ANOSMIA 145 0.0100
874 DELUSION 155 0.0100
875 CHOKING 193 0.0099
876 HAEMORRHAGE 1031 0.0099
877 VAGINAL HAEMORRHAGE 426 0.0098
878 CONVULSION 559 0.0098
879 WHITE BLOOD CELL COUNT DECREASED 1059 0.0098
880 ABNORMAL BEHAVIOUR 386 0.0097
881 MULTI-ORGAN FAILURE 168 0.0097
882 DRUG EFFECT INCOMPLETE 352 0.0097
883 BLOOD POTASSIUM INCREASED 157 0.0097
884 SKIN EXFOLIATION 804 0.0095
885 INJECTION SITE BRUISING 757 0.0095
886 UNEVALUABLE EVENT 709 0.0094
887 NERVOUS SYSTEM DISORDER 292 0.0093
888 INJECTION SITE REACTION 642 0.0093
889 INCORRECT PRODUCT ADMINISTRATION DURATION 202 0.0093
890 ASCITES 274 0.0093
891 THYROID DISORDER 143 0.0093
892 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1671 0.0093
893 PSYCHOTIC DISORDER 273 0.0092
894 PREMATURE BABY 277 0.0092
895 INCREASED APPETITE 174 0.0091
896 THERAPY CESSATION 464 0.0090
897 PERITONITIS 187 0.0090
898 VENTRICULAR TACHYCARDIA 148 0.0090
899 PRODUCT DOSE OMISSION 584 0.0089
900 MANIA 147 0.0089
901 OSTEONECROSIS 292 0.0089
902 DRUG PRESCRIBING ERROR 170 0.0088
903 DRY SKIN 1177 0.0088
904 INJECTION SITE WARMTH 179 0.0087
905 PAIN OF SKIN 233 0.0086
906 METASTASES TO LIVER 152 0.0086
907 DIABETES MELLITUS INADEQUATE CONTROL 153 0.0086
908 PRODUCT DOSE OMISSION ISSUE 2526 0.0086
909 INJECTION SITE RASH 262 0.0085
910 CYTOKINE RELEASE SYNDROME 169 0.0084
911 PRODUCT SUBSTITUTION ISSUE 485 0.0084
912 INJECTION SITE ERYTHEMA 1036 0.0083
913 ISCHAEMIC STROKE 149 0.0083
914 INJECTION SITE PRURITUS 554 0.0083
915 HEPATIC FUNCTION ABNORMAL 307 0.0082
916 VISUAL ACUITY REDUCED 273 0.0082
917 EXTRA DOSE ADMINISTERED 331 0.0082
918 INCORRECT DRUG ADMINISTRATION DURATION 229 0.0081
919 DRUG EFFECT DECREASED 438 0.0081
920 HYPOACUSIS 349 0.0081
921 INTESTINAL OBSTRUCTION 303 0.0080
922 INCORRECT DOSE ADMINISTERED 1799 0.0079
923 OCULAR HYPERAEMIA 372 0.0078
924 FEMUR FRACTURE 241 0.0078
925 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 181 0.0078
926 DERMATITIS ATOPIC 408 0.0077
927 CEREBRAL HAEMORRHAGE 277 0.0077
928 NEUTROPHIL COUNT DECREASED 314 0.0077
929 INJECTION SITE SWELLING 590 0.0077
930 FEBRILE NEUTROPENIA 507 0.0076
931 GLAUCOMA 147 0.0076
932 UNDERDOSE 552 0.0076
933 PRODUCT PHYSICAL ISSUE 152 0.0075
934 HIP FRACTURE 242 0.0075
935 INJECTION SITE URTICARIA 184 0.0075
936 DRUG ADMINISTRATION ERROR 230 0.0075
937 CARDIAC DISORDER 701 0.0075
938 EYE PRURITUS 250 0.0074
939 NEOPLASM PROGRESSION 257 0.0074
940 DIABETIC KETOACIDOSIS 177 0.0074
941 DEVICE DISLOCATION 319 0.0073
942 INJECTION SITE MASS 270 0.0073
943 CLOSTRIDIUM DIFFICILE INFECTION 157 0.0072
944 PLATELET COUNT DECREASED 763 0.0072
945 SKIN BURNING SENSATION 510 0.0071
946 CEREBROVASCULAR ACCIDENT 1203 0.0071
947 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 505 0.0071
948 FULL BLOOD COUNT DECREASED 142 0.0070
949 CARDIAC FAILURE 563 0.0070
950 NEUTROPENIA 945 0.0069
951 EYE IRRITATION 399 0.0069
952 SKIN IRRITATION 317 0.0069
953 THERAPY INTERRUPTED 494 0.0069
954 MYOCARDIAL INFARCTION 1200 0.0069
955 DRUG WITHDRAWAL SYNDROME 598 0.0068
956 DISEASE PROGRESSION 801 0.0068
957 PRODUCT QUALITY ISSUE 915 0.0067
958 CEREBRAL INFARCTION 164 0.0067
959 PRODUCT PRESCRIBING ISSUE 146 0.0067
960 CARDIAC FAILURE CONGESTIVE 537 0.0067
961 MENSTRUATION IRREGULAR 179 0.0067
962 INJECTION SITE PAIN 2045 0.0067
963 NEOPLASM MALIGNANT 433 0.0065
964 BLINDNESS 264 0.0065
965 DRUG DOSE OMISSION 1062 0.0064
966 PRODUCT AVAILABILITY ISSUE 144 0.0063
967 ACNE 472 0.0062
968 HOSPITALISATION 933 0.0061
969 WRONG TECHNIQUE IN DRUG USAGE PROCESS 217 0.0060
970 DEVICE ISSUE 521 0.0058
971 INJECTION SITE HAEMORRHAGE 458 0.0057
972 GLYCOSYLATED HAEMOGLOBIN INCREASED 143 0.0057
973 DEMENTIA 150 0.0054
974 MALIGNANT NEOPLASM PROGRESSION 540 0.0053
975 BLOOD GLUCOSE INCREASED 973 0.0052
976 BLOOD GLUCOSE DECREASED 244 0.0051
977 PRODUCT ADHESION ISSUE 180 0.0050
978 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 144 0.0049
979 DEVICE BREAKAGE 197 0.0048
980 DRUG DEPENDENCE 733 0.0046
981 DEVICE MALFUNCTION 314 0.0045
982 ACCIDENTAL EXPOSURE TO PRODUCT 455 0.0044
983 DRUG EXPOSURE DURING PREGNANCY 150 0.0044
984 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 850 0.0042
985 NO ADVERSE EVENT 755 0.0042
986 PLASMA CELL MYELOMA 150 0.0038
987 INTERSTITIAL LUNG DISEASE 185 0.0038
988 DEATH 3184 0.0037
989 LUNG NEOPLASM MALIGNANT 144 0.0035
990 BREAST CANCER 291 0.0031
991 DEVICE EXPULSION 158 0.0024
992 PROSTATE CANCER 189 0.0023
993 DEVICE DIFFICULT TO USE 151 0.0023
994 PRODUCT STORAGE ERROR 177 0.0020